Fiona MacLaughlin

Dr. MacLaughlin joined Johnson & Johnson Development Corporation (JJDC) in May 2020 as Senior Director, Venture Investments, and is based in London, UK at the Johnson & Johnson Innovation Centre. She brings >20 years of experience in Life Sciences, in particular founding companies and financing early stage life science technologies. Fiona’s responsibilities are focused on investing in and managing portfolio investments in the pharmaceuticals and biotechnology areas in Europe.

Previously she was a Director at Inkef Capital where she led investments in and sat on the Boards of a number of portfolio companies. Before that, Fiona was an Associate at Advent Life Sciences, during which time she co-founded Boston-based Arrakis Therapeutics Inc and helped build a number of early stage companies. Her interest in innovation came from her prior role as a Business Development Manager in the Technology Transfer Division of the Wellcome Trust. There she evaluated early stage product development opportunities and investments for Translational Funding, established and ran the £45M “R&D for Affordable Healthcare” fund, a joint venture with the Indian Government supporting development of new technologies in India, and was part of the founding team with Merck & Co Inc, a joint venture leading to the formation of the Hilleman Laboratories, Delhi. Prior to joining Wellcome, Fiona was held senior operational roles in a number of biotech/medtech companies. She is a Pharmacist by training and has a PhD in drug delivery (Nottingham University).